Source-grounded facts extracted from Definitive Healthcare Corp.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Definitive Healthcare Corp. shareholders approved Advisory vote on the compensation of the Company's named executive officers at the 2026-06-04 meeting.
“Proposal 4 – Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The results of such vote were: For Against Abstain Broker Non-Votes 108,811,271 12,680,719 19,223 10,023,267”
Definitive Healthcare Corp. shareholders approved Approval of an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan to increase the number of shares of Class A common stock available for grant by 15,000,000 at the 2026-06-04 meeting.
“Proposal 3 – Share Increase Proposal The stockholders approved an amendment to the 2021 Plan, to increase the number of shares of Common Stock that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. The results of such vote were: For Against Abstain Broker Non-Votes 105,140,642 16,351,580 18,991 10,023,267”
Definitive Healthcare Corp. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-04 meeting.
“Proposal 2 – Ratification of Selection of Independent Public Registered Accounting Firm The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The results of such vote were: For Against Abstain 130,745,809 726,699 61,972”
Definitive Healthcare Corp. shareholders approved Election of each of the nominees for Class II directors at the 2026-06-04 meeting.
“Proposal 1 – Election of Directors The stockholders elected each of the three nominees named below as Class II directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The results of such vote were: Director Nominee For Withheld Broker Non-Votes Chris Egan 115,632,170 5,879,043 10,023,267 Sastry Chilukuri 114,385,076 7,126,137 10,023,267 Samuel A. Hamood 118,977,114 2,534,099 10,023,267”
Definitive Healthcare Corp. reported Q1 2026 results: revenue $55.9 million, net income $(192.4) million.
“First Quarter 2026 Financial Highlights: • Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. • Net Loss , inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue.”
Definitive Healthcare Corp. terminated Nominating Agreement with SE VII DHC AIV, L.P. (effective 2026-04-03).
“the Company and Spectrum entered into a termination agreement that permanently and irrevocably terminated the Nominating Agreement in its entirety.”
Richard Booth departed as Chief Financial Officer at Definitive Healthcare Corp..
“The Company previously announced that Richard Booth, the Company’s current CFO, would be departing the Company effective June 1, 2025.”
Casey Heller was appointed as Chief Financial Officer at Definitive Healthcare Corp..
“On February 24, 2025, the Board of Directors (the “Board”) of the Company appointed Casey Heller to the position of Chief Financial Officer (“CFO”) effective June 2, 2025.”
Richard Booth departed as Chief Financial Officer at Definitive Healthcare Corp..
“Richard Booth, the Company’s Chief Financial Officer, and the Company agreed that Mr. Booth will be leaving the Company effective June 1, 2025.”
Kate Shamsuddin Jensen changed role as Chief Operating Officer at Definitive Healthcare Corp..
“On September 29, 2024, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) promoted Kate Shamsuddin Jensen, the Company’s current Chief Strategy Officer, to the role of Chief Operating Officer, effective as of October 1, 2024 (the “Effective Date”).”
Carrie Lazorchak resigned as Chief Revenue Officer at Definitive Healthcare Corp..
“On July 24, 2024, Carrie Lazorchak, the Chief Revenue Officer of the Company, provided the Company with notice of her resignation, effective August 2, 2024.”
Jason Krantz departed as Interim Chief Executive Officer at Definitive Healthcare Corp..
“Effective on the Start Date, Jason Krantz, the Company’s founder, Executive Chairman of the Board and current Interim CEO will step down from his role as Interim CEO and continue to serve as Executive Chairman of the Board.”
Kevin Coop was appointed as Chief Executive Officer at Definitive Healthcare Corp..
“On May 20, 2024, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) appointed Kevin Coop to the position of Chief Executive Officer (“CEO”) and as a member of the Board, each effective June 24, 2024 (the “Start Date”).”
Definitive Healthcare Corp. reported first quarter ended March 31, 2024 results: revenue $63.5 million, net income $(12.7) million.
“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,”
Definitive Healthcare Corp. updated its the quarter ended December 31, 2023 guidance (reaffirmed).
“On January 16, 2024, Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) issued a press release announcing the management changes described in Item 5.02 below and its reaffirmation of previously announced guidance for the quarter ended December 31, 2023.”
Jason Krantz was appointed as Interim Chief Executive Officer at Definitive Healthcare Corp..
“On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.”
Robert Musslewhite departed as Chief Executive Officer at Definitive Healthcare Corp..
“On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024”
Definitive Healthcare Corp. announced a restructuring with charges of pre-tax cash restructuring and related charges to its GAAP financial results of approximately $6.5 million to $7.2 million, consisting primarily of severance pa (reduction of the Company’s current workforce by 154 people).
“On January 3, 2024, the Company committed to a restructuring plan (the “Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan provides for a reduction of the Company’s current workforce by 154 people. The Company estimates that in the first half of 2024 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $6.5 million to $7.2 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as an approximate $1.5 million non-cash charge related to the vesting of share-based awards for employees who are terminated.”
Definitive Healthcare Corp. reported the quarter ended September 30, 2023 results: revenue $65.3 million, net income $(248.7) million.
“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023 Third quarter revenue grew 14% year-over-year to $65.3 million Framingham, MA (November 2, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,”
Joseph Mirisola was appointed as Senior Advisor at Definitive Healthcare Corp..
“In addition, Mr. Mirisola will cease to be Chief Revenue Officer effective November 1, 2023 and will, at such time, become a Senior Advisor.”
Scott Stephenson was appointed as Director at Definitive Healthcare Corp..
“Following Mr. Mitchell’s resignation, on September 6, 2023, the Board appointed Scott Stephenson as a member of the Board and as a member of the Nominating and Corporate Governance Committee of the Board.”
Chris Mitchell resigned as Director at Definitive Healthcare Corp..
“On September 6, 2023, Chris Mitchell resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”), which resignation became effective upon the appointment of Scott Stephenson as a member of the Board on September 6, 2023.”
Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income ($11.6) million.
“Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023 Second quarter revenue grew 12% year-over-year to $61.0 million”
Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income in the range of $11.4 million to $11.8 million or $(0.08) per share, EPS $(0.08) per share. Guidance reaffirmed.
“Second Quarter 2023 Financial Highlights: • Revenue is expected to be $61.0 million • Net loss is expected to be in the range of $11.4 million to $11.8 million or $(0.08) per share • Adjusted Net Income is expected to be in the range of $12.3 million to $12.4 million or $0.08 per diluted share • Adjusted EBITDA is expected to be $17.2 million”
Definitive Healthcare Corp. announced a restructuring with charges of approximately $1.8 million to $2.0 million (42 people, or approximately 4 percent of its total workforce).
“On July 27, 2023, the Company committed to a restructuring plan (the “Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan provides for a reduction of the Company’s current workforce by 42 people, or approximately 4 percent of its total workforce. The Company estimates that in the third quarter of 2023 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $1.8 million to $2.0 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as a non-cash charge related to the vesting of share-based awards for employees who are terminated.”
Joseph Mirisola resigned as Chief Revenue Officer at Definitive Healthcare Corp..
“On June 8, 2023, Joseph Mirisola notified the Board of Directors of Definitive Healthcare Corp. (NASDAQ:DH) (the “Company”) of his intent to resign as its Chief Revenue Officer.”
Definitive Healthcare Corp. shareholders approved Ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2023 at the 2023-06-01 meeting.
“Proposal #3: For Against Abstain Ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2023 144,466,280 2,468,804 32,159”
Definitive Healthcare Corp. shareholders approved Frequency of Future Advisory Vote on Named Executive Officer Compensation at the 2023-06-01 meeting.
“Proposal #2: 1 Year 2 Years 3 Years Abstain Broker Non-Votes Frequency of Future Advisory Vote on Named Executive Officer Compensation 144,374,698 305,719 218,960 4,249 2,063,617”
Definitive Healthcare Corp. shareholders approved Election of Class II Directors at the 2023-06-01 meeting.
“Proposal #1: For Withhold Broker Non-Votes Election of Chris Egan 141,973,375 2,930,251 2,063,617 Election of Samuel A. Hamood 142,001,523 2,902,103 2,063,617 Election of Jill Larsen 130,600,677 14,302,949 2,063,617 Election of Sastry Chilukuri 143,372,138 1,531,488 2,063,617”
Definitive Healthcare Corp. reported the quarter ended March 31, 2023 results: revenue $59.2 million, net income ($15.6) million.
“--- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA (May 4, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence,”
Definitive Healthcare Corp. reported full year ended December 31, 2022 results: revenue $222.7 million, net income $(22.3) million. Guidance initiated.
“Full Year 2022 Financial Highlights: • Revenue was $222.7 million for the year, an increase of 34% from $166.2 million for the full year 2021. • GAAP Net loss was $(22.3) million, or 10% of revenue, compared to $(61.3) million, or 37% of revenue for the full year 2021.”
Definitive Healthcare Corp. reported fourth quarter ended December 31, 2022 results: revenue $60.6 million, net income $6.7 million. Guidance initiated.
“Fourth Quarter 2022 Financial Highlights: • Revenue was $60.6 million, an increase of 31% from $46.3 million in Q4 2021. • GAAP Net Income (loss) was $6.7 million, or 11% of revenue, compared to $(14.8) million, or 32% of revenue in Q4 2021.”
Definitive Healthcare Corp. announced a restructuring with charges of $2.0 million to $2.5 million (approximately 55 people, or approximately 6 percent of its total workforce).
“The Plan provides for a reduction of the Company’s current workforce by approximately 55 people, or approximately 6 percent of its total workforce. The Company estimates that in the first quarter of 2023 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $2.0 million to $2.5 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as an immaterial non-cash stock-based compensation charge related to the vesting of share-based awards for employees who are terminated.”
Definitive Healthcare Corp. reported Full Year 2022 results: revenue in the range of $220 – $221 million, net income expected to be $30 – 31 million, EPS $0.19– $0.20. Guidance raised.
“Revenue is expected to be in the range of $220 – $221 million, an increase of 33% from prior year at the midpoint.”
Definitive Healthcare Corp. reported the third quarter ended September 30, 2022 results: revenue $57.4 million, net income ($6.4) million. Guidance raised.
“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2022 Third quarter revenue grew 33% year-over-year to $57.4 million Framingham, MA (November 3, 2022) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence,”
Jonathan Maack was appointed as President at Definitive Healthcare Corp..
“On November 3, 2022, the Company announced that, on September 16, 2022, its Board of Directors (the "Board") appointed Jonathan Maack to the position of President, effective November 3, 2022 (the "Effective Date").”
Sastry Chilukuri was appointed as Director at Definitive Healthcare Corp..
“the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).”
D. Randall Winn resigned as Director at Definitive Healthcare Corp..
“On September 29, 2022, D. Randall Winn resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”), which resignation became effective upon the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).”
Jason Krantz changed role as Executive Chairman at Definitive Healthcare Corp..
“Effective on August 1, 2022, Jason Krantz, the Company’s founder, Chairman of the Board and current CEO will step down from his role as CEO, and become Executive Chairman of the Board.”
Robert Musslewhite was appointed as Chief Executive Officer at Definitive Healthcare Corp..
“On May 5, 2022, the Company announced that on May 3, 2022 its Board of Directors (the “Board”) appointed Robert Musslewhite, the Company’s current President, to the position of Chief Executive Officer (“CEO”), effective August 1, 2022.”
Robert Musslewhite was appointed as President at Definitive Healthcare Corp..
“Effective on October 7, 2021, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) appointed Robert Musslewhite as President of the Company.”
Kathleen A. Winters was elected as Director at Definitive Healthcare Corp..
“On October 1, 2021, Ms. Kathleen A. Winters was elected to the board of directors (the “Board”) and the Audit Committee of the Board of Definitive Healthcare Corp.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.